Drug Interactions With Cannabidiol (CBD): A Review of Reports to the FDA Adverse Event Reporting System (FAERS)

Yannis Lafazanos, Robert Mowery, Matthew Randall, Nies Dang, Eli Ehrenpreis, Advocate Gastroenterology Faculty - Lutheran General, Advocate Internal Medicine Residents - Lutheran General, Eli Ehrenpreis

Research output: Contribution to journalMeeting abstract

Original languageAmerican English
JournalScientific Day
StatusPublished - Oct 15 2024

Keywords

  • Cannabidiol (CBD)
  • Drug interactions
  • CYP450

Cite this